Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and August 2016

Showing 1 to 10 of 301
Title Reference number Published Last updated
Bosutinib for previously treated chronic myeloid leukaemia Reference number:TA401 TA00401 Published:August 2016 20160801 Last updated:August 2016 20160824
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin Reference number:TA402 TA00402 Published:August 2016 20160801 Last updated:August 2016 20160824
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer Reference number:TA403 TA00403 Published:August 2016 20160801 Last updated:August 2016 20160824
Degarelix for treating advanced hormone-dependent prostate cancer Reference number:TA404 TA00404 Published:August 2016 20160801 Last updated:August 2016 20160824
Trifluridine–tipiracil for previously treated metastatic colorectal cancer Reference number:TA405 TA00405 Published:August 2016 20160801 Last updated:August 2016 20160824
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel Reference number:TA391 TA00391 Published:May 2016 20160501 Last updated:August 2016 20160824
Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation Reference number:TA398 TA00398 Published:July 2016 20160701 Last updated:July 2016 20160727
Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts Reference number:TA399 TA00399 Published:July 2016 20160701 Last updated:July 2016 20160727
Nivolumab in combination with ipilimumab for treating advanced melanoma Reference number:TA400 TA00400 Published:July 2016 20160701 Last updated:July 2016 20160727
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated Reference number:TA387 TA00387 Published:April 2016 20160401 Last updated:July 2016 20160727